Cysts, fibrosis, and tubular degeneration form the typical triad of pathologies leading to the gradual decline in kidney ...

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

One of the most striking claims in the review is that AI-based classification models can meet or exceed the performance of ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver ...

On Monday, StopAntisemitism—an advocacy group aimed at combating antisemitism, but which has faced criticism for targeting ...

Reggie Bird has opened up about the devastating moment she learned that her son Lucas was diagnosed with cystic fibrosis (CF).

A repurposed anti-cancer drug, Cilengitide, was found to reduce kidney scarring and slow disease progression in preclinical ...

Researchers predict a steady increase in fatty liver disease in the U.S. population, but there's not a lot of treatment options available.

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a ...